These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8215090)

  • 41. Detection of illicit drugs in oral fluid from drivers as biomarker for drugs in blood.
    Gjerde H; Langel K; Favretto D; Verstraete AG
    Forensic Sci Int; 2015 Nov; 256():42-5. PubMed ID: 26295911
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urine testing for cocaine abuse: metabolic and excretion patterns following different routes of administration and methods for detection of false-negative results.
    Cone EJ; Sampson-Cone AH; Darwin WD; Huestis MA; Oyler JM
    J Anal Toxicol; 2003 Oct; 27(7):386-401. PubMed ID: 14606991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of two extraction procedures for determination of drugs of abuse in human saliva by high-performance liquid chromatography.
    Fernández P; Morales L; Vázquez C; Lago M; Bermejo AM
    J Appl Toxicol; 2008 Nov; 28(8):998-1003. PubMed ID: 18615842
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Workplace testing of drugs of abuse and psychotropic drugs].
    Mura P; Saussereau E; Brunet B; Goullé JP
    Ann Pharm Fr; 2012 May; 70(3):120-32. PubMed ID: 22655580
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Saliva testing--a nontraditional diagnostic tool.
    Miller SM
    Clin Lab Sci; 1994; 7(1):39-44. PubMed ID: 10172036
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic drug monitoring and drugs of abuse testing on the cobas 6000 analyzer series: analytical performance under routine-like conditions.
    Brandhorst G; Luthe H; Domke I; Knoke C; Rhode KH; Sauter H; Oellerich M
    Clin Chem Lab Med; 2009; 47(7):854-9. PubMed ID: 19496737
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urine drug testing results and paired oral fluid comparison from patients enrolled in long-term medication-assisted treatment in Tennessee.
    Miller KL; Puet BL; Roberts A; Hild C; Carter J; Black DL
    J Subst Abuse Treat; 2017 May; 76():36-42. PubMed ID: 28131519
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hair: a complementary source of bioanalytical information in forensic toxicology.
    Barroso M; Gallardo E; Vieira DN; López-Rivadulla M; Queiroz JA
    Bioanalysis; 2011 Jan; 3(1):67-79. PubMed ID: 21175368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Screening for drugs of abuse: which matrix, oral fluid or urine?
    Allen KR
    Ann Clin Biochem; 2011 Nov; 48(Pt 6):531-41. PubMed ID: 21885472
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interpretation of oxycodone concentrations in oral fluid.
    Moore C; Kelley-Baker T; Lacey J
    J Opioid Manag; 2012; 8(3):161-6. PubMed ID: 22798176
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trends in drug testing in oral fluid and hair as alternative matrices.
    Wille SM; Baumgartner MR; Fazio VD; Samyn N; Kraemer T
    Bioanalysis; 2014 Aug; 6(17):2193-209. PubMed ID: 25383732
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists.
    Davey J; Leal N; Freeman J
    Drug Alcohol Rev; 2007 May; 26(3):301-7. PubMed ID: 17454020
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drugs of abuse in oral fluid collected by two different sample kits--stability testing and validation using ultra performance tandem mass spectrometry analysis.
    Lund HM; Øiestad EL; Gjerde H; Christophersen AS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3367-77. PubMed ID: 21962269
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs.
    Heltsley R; DePriest A; Black DL; Robert T; Marshall L; Meadors VM; Caplan YH; Cone EJ
    J Anal Toxicol; 2011 Oct; 35(8):529-40. PubMed ID: 22004671
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparing drug detection in oral fluid and blood: data from a national sample of nighttime drivers.
    Kelley-Baker T; Moore C; Lacey JH; Yao J
    Traffic Inj Prev; 2014; 15(2):111-8. PubMed ID: 24345011
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of ten oral fluid point-of-collection drug-testing devices.
    Walsh JM; Crouch DJ; Danaceau JP; Cangianelli L; Liddicoat L; Adkins R
    J Anal Toxicol; 2007; 31(1):44-54. PubMed ID: 17389083
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers.
    Vindenes V; Lund HM; Andresen W; Gjerde H; Ikdahl SE; Christophersen AS; Øiestad EL
    Forensic Sci Int; 2012 Jun; 219(1-3):165-71. PubMed ID: 22284072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.
    Pehrsson A; Gunnar T; Engblom C; Seppä H; Jama A; Lillsunde P
    Forensic Sci Int; 2008 Mar; 175(2-3):140-8. PubMed ID: 17640837
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alternative specimens for workplace drug testing.
    Caplan YH; Goldberger BA
    J Anal Toxicol; 2001; 25(5):396-9. PubMed ID: 11499896
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral fluid and hair in workplace drug testing programs: new technology for immunoassays.
    Moore C
    Drug Test Anal; 2011 Mar; 3(3):166-8. PubMed ID: 21425472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.